OPKO Health
OPK
$1.56
Share price
-3.70%
Change (1 day)
-39.06%
Change (1 year)
Operating Margin for OPKO Health (OPK)
Operating Margin as of June 2023 (TTM): -36.36%
According to OPKO Health 's latest financial reports and stock price the company's current Operating Margin is -36.36%. At the end of 2021 the company had an Operating Margin of -0.79%.
Operating Margin history for OPKO Health from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -0.79% | -123.3% |
| 2020 | 3.39% | -110.03% |
| 2019 | -33.81% | 88.88% |
| 2018 | -17.90% | -30.65% |
| 2017 | -25.81% | 328.76% |
| 2016 | -6.02% | -78.55% |
| 2015 | -28.06% | -85.05% |
| 2014 | -187.68% | 73.84% |
| 2013 | -107.96% | 36.49% |
| 2012 | -79.10% | -8.67% |
| 2011 | -86.61% | 76.76% |
| 2010 | -49.00% | -78.57% |
| 2009 | -228.60% | -45.94% |
| 2008 | -422.85% | -98.66% |
| 2007 | -31,624.44% | |
| 2003 | -44,561.54% | 2317.8% |
| 2002 | -1,843.06% | 177.07% |
| 2001 | -665.19% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 24.28% | -166.78% | 🇺🇸 USA |
 Abbott Laboratories ABT | 16.84% | -146.31% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 39.91% | -209.76% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.18% | -152.75% | 🇺🇸 USA |
 LabCorp LH | 19.39% | -153.33% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -100.93% | 177.59% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 4.14% | -111.39% | 🇮🇱 Israel |
 Ardelyx ARDX | -128.83% | 254.32% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.